APA (7th ed.) Citation

Sinclair, R., Mesinkovska, N., Mitra, D., Wajsbrot, D., Law, E. H., Wolk, R., & King, B. (2025). Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial: Effect of Ritlecitinib on Patient-Reported Hair Loss in Patients with Alopecia Areata: R. Sinclair et al. American Journal of Clinical Dermatology, 26(1), 109. https://doi.org/10.1007/s40257-024-00899-4

Chicago Style (17th ed.) Citation

Sinclair, Rodney, Natasha Mesinkovska, Debanjali Mitra, Dalia Wajsbrot, Ernest H. Law, Robert Wolk, and Brett King. "Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial: Effect of Ritlecitinib on Patient-Reported Hair Loss in Patients with Alopecia Areata: R. Sinclair Et Al." American Journal of Clinical Dermatology 26, no. 1 (2025): 109. https://doi.org/10.1007/s40257-024-00899-4.

MLA (9th ed.) Citation

Sinclair, Rodney, et al. "Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial: Effect of Ritlecitinib on Patient-Reported Hair Loss in Patients with Alopecia Areata: R. Sinclair Et Al." American Journal of Clinical Dermatology, vol. 26, no. 1, 2025, p. 109, https://doi.org/10.1007/s40257-024-00899-4.